Ind-Swift Laboratories is trading at ₹326.35, down 5.50%; no clear company-specific announcement explaining the October 23, 2026 decline surfaced in the search. - Available reporting on October 22 described broad Indian-market pressure, citing rising crude prices, Middle East tensions, weak Asian equities and global uncertainty. - These market-wide factors are the most plausible context, but sources do not directly attribute Ind-Swift Laboratories’ decline to them.